News in the Life Sciences Industry | |
Results 301 - 320 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Global Hematologic Malignancies Testing Market 2019-2025: Increasing Adoption of Inorganic Growth Strategies in the Market |
DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Canopy Biosciences Acquires Core Diagnostics |
ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for biopharmaceutical researchers. With the acquisition of Core Diagnostics, Canopy Biosciences will be able to... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Related companies: Canopy Biosciences |
Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China |
SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Bionorica selects Movilitas Services and Solutions for Compliance with the Russian Serialization Law |
COLUMBIA, Md., Dec. 4, 2019 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply chain ecosystems, announced today that Bionorica, one of the leading global manufacturers of herbal... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market |
- Global Biomarkers Market Forecast to 2029 Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Brachytherapy Proves Effective in Treating Skin Cancer |
CHICAGO, Dec. 4, 2019 /PRNewswire/ -- The use of high-dose-rate brachytherapy to treat elderly patients with common skin cancers offers excellent cure rates and cosmetic outcomes, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA). ... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Study Finds Key Brain Region Smaller in Birth Control Pill Users |
CHICAGO, Dec. 4, 2019 /PRNewswire/ -- Researchers studying the brain found that women taking oral contraceptives, commonly known as birth control pills, had significantly smaller hypothalamus volume, compared to women not taking the pill, according to a new study presented today at the annual... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Global Cytogenetics Technologies, Companies & Markets, 2018-2023 & 2028 |
DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Care Dimensions Improves Quality of Life for Hospice Patients Using Telehealth |
DANVERS, Mass., Dec. 4, 2019 /PRNewswire/ -- Care Dimensions has achieved an average 30-day hospital readmission rate of 1.38% over one year for hospice patients enrolled in the telehealth program. In 2018, Care Dimensions partnered with Health Recovery Solutions (HRS), a nationally recognized... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Okayama University Research - Primary Intraocular Lymphoma Does Not Always Spread to the Central Nervous System |
OKAYAMA, Japan, Dec. 4, 2019 /PRNewswire/ -- Researchers at Okayama University report in the Journal of Clinical and Experimental Hematopathology that primary intraocular lymphoma, a cancer in the eye, does not always develop into central nervous system lymphoma. In addition, the scientists... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Global Biomarkers Companies, Technologies, Markets 2018-2028: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics |
DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China |
SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
ViewRay Announces Pricing of Public Offering of Common Stock |
CLEVELAND, Dec. 4, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 41,550,000 shares of common stock... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Related companies: ELEKTA AB | Medtronic Plc | ViewRay, Inc. |
CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications |
ROCKVILLE, Md. and BEIJING, Dec. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Product Administration... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Related companies: CASI Pharmaceuticals, Inc. |
Kodiak Sciences Announces Pricing of $276.0 Million Public Offering of Common Stock |
PALO ALTO, Calif., Dec. 3, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Related companies: Kodiak Sciences Inc. |
Relmada Therapeutics Announces Pricing of Public Offering of Common Stock |
NEW YORK, Dec. 3, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the pricing of an offering of 3,333,334 shares of its common stock at a public offering... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Related companies: Relmada Therapeutics, Inc. |
Zelira Therapeutics Expands HOPE® Distribution In The U.S.A |
PERTH, Australia, Dec. 3, 2019 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelira), formerly Zelda Therapeutics Ltd, announced today it will bring its HOPE® Franchise to the state of Louisiana with a licensing agreement that will generate immediate revenue through a licensing... Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Global mobile cardiac telemetry devices market is expected to grow with a CAGR of 11.60% over the forecast period from 2019-2025 |
The report on the global mobile cardiac telemetry devices market provides qualitative and quantitative analysis for the period from 2017 to 2025. |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Global MRI guided neurosurgical ablation market is expected to grow with a CAGR of 4.1% over the forecast period from 2019-2025 |
The report on the global MRI guided neurosurgical ablation market provides qualitative and quantitative analysis for the period from 2017 to 2025. |
By: PR Newswire Association LLC. - 04 Dec 2019 |
Global nanopharmaceuticals market is expected to grow with a CAGR of 22.10% over the forecast period from 2019-2025 |
The report on the global nanopharmaceuticals market provides qualitative and quantitative analysis for the period from 2017 to 2025. Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2019 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Upcoming Life Sciences Events
- December 2019
- Marseille: BioFIT
- London: Genesis 2019
- London: The Pharma Business Development Course